LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹10 Cr | ₹-41 Cr | ₹93 Cr | ₹-29 Cr | ₹27 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LAURUS LABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹10 Cr |
| Mar2025 | ₹-41 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹-29 Cr |
| Mar2022 | ₹27 Cr |
How is Net Cash Inflow / Outflow of LAURUS LABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹10 Cr | Positive | |
| Mar2025 | ₹-41 Cr | Negative | |
| Mar2024 | ₹93 Cr | Positive | |
| Mar2023 | ₹-29 Cr | Negative | |
| Mar2022 | ₹27 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹132,373.5 Cr | 6.2% | 20.6% | 141.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 6.2% |
20.6% |
141.1% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses